首页> 外文期刊>Drug delivery. >Development and characterization of sponge-like acyclovir ocular minitablets.
【24h】

Development and characterization of sponge-like acyclovir ocular minitablets.

机译:海绵状阿昔洛韦眼小片的研制与表征。

获取原文
获取原文并翻译 | 示例
       

摘要

For the treatment of ocular keratitis acyclovir, as a highly specific inhibitor of herpes virus replication, is applied topically into the eye. The objective of this study was to design and evaluate freeze-dried, bioadhesive and biodegredable acyclovir ocular minitablets for prolonged local drug action. The sponge-like nature of the lyophilized ocular minitablets ensures rapid hydration and gelation of these tablets in the eye and thus would reduce the foreign body sensation. The polymers used were sodium carboxymethylcellulose (NaCMC), hydroxypropylmethylcellulose (HPMC), xanthan gum, chitosan and Carbopol 943P. The minitablets were evaluated for drug content, weight variation, bioadhesion, water uptake and in vitro drug release. In addition, the rheological characteristics of the polymers solutions were investigated. Rheological data revealed that all tested polymers exhibited pseudoplastic behaviour which is required to minimize interference with blinking. Drug release was found to be affected by the type and concentration of polymer. The order of sustainment was chitosan > xanthan > HPMC > Carbopol > NaCMC. Water uptake study, dissolution rate of the polymers and viscosity measurements could explain the different release profiles of the drug from the polymers. Chitosan minitablet was chosen for its significant sustained release and good bioadhesive property for in vivo study in rabbits. The tablet showed a good permeation into the cornea in comparison to the commercially available Zovirax((R)) eye ointment. In conclusion, chitosan ocular minitablets containing acyclovir could be considered as a promising sustained drug delivery system for ocular keratitis treatment.
机译:为了治疗眼角膜炎,阿昔洛韦作为疱疹病毒复制的高度特异性抑制剂,局部施用于眼睛。这项研究的目的是设计和评估冷冻干燥,生物粘附性和可生物降解的阿昔洛韦眼用微型片剂,以延长局部药物作用。冻干的眼用微型片剂具有海绵状性质,可确保这些片剂在眼中迅速水合和凝胶化,从而减少异物感。使用的聚合物是羧甲基纤维素钠(NaCMC),羟丙基甲基纤维素(HPMC),黄原胶,壳聚糖和Carbopol 943P。评估微型片剂的药物含量,重量变化,生物粘附性,吸水率和体外药物释放。此外,还研究了聚合物溶液的流变特性。流变数据表明,所有测试的聚合物均表现出假塑性行为,这是使眨眼干扰最小化所必需的。发现药物释放受聚合物类型和浓度的影响。维持的顺序是壳聚糖>黄原胶> HPMC> Carbopol> NaCMC。吸水率研究,聚合物的溶解速率和粘度测量结果可以解释药物从聚合物中释放的不同方式。选择壳聚糖微型片剂是因为其具有显着的持续释放和良好的生物粘附特性,可用于兔体内研究。与市售的眼药膏相比,该片剂显示出良好的渗透入角膜的能​​力。总之,壳聚糖含阿昔洛韦的眼用微型片剂可被视为治疗眼角膜炎的有希望的持续药物输送系统。

著录项

  • 来源
    《Drug delivery.》 |2011年第1期|共8页
  • 作者

    Refai H; Tag R;

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

  • 入库时间 2022-08-18 22:41:18

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号